Study: SI-BONE is a clear winner at 2 years out

By

SI-BONE: IFUSE SHINES IN RCT (Orthopedics This Week)
SI-BONE, Inc. is announcing two-year results from the INSITE (Investigation of Sacroiliac Fusion Treatment) study, a prospective randomized controlled trial (RCT) of MIS (minimally invasive surgery) SI (sacroiliac) joint fusion with iFuse compared to non-surgical management (NSM).
According to the August 24, 2016 news release, the researchers found that “rapid improvements in pain, disability and quality of life for the iFuse group were larger than those seen for the NSM group and were durable to two years…148 subjects were enrolled, randomi...

Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.